Dialogue on how to overcome clinical inertia with regard to SGLT2i
Media formats available:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Recommended
- Teaming up to tackle cardiorenal risk in diabetes - Role of SGLT2i: How to overcome clinical inertiaIntroduction on tackling cardiorenal risk in diabetes
Prof. Melanie Davies, MD
- Teaming up to tackle cardiorenal risk in diabetes - Role of SGLT2i: How to overcome clinical inertiaSymposium on the role of SGLT2i in tackling cardiorenal risk in diabetes
Prof. Melanie Davies, MD
Prof. Nikolaus Marx, MD
- Teaming up to tackle cardiorenal risk in diabetes - Role of SGLT2i: How to overcome clinical inertiaSGLT2i: Overview of recent trials and guideline recommendations
Prof. Nikolaus Marx, MD
